v3.26.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net income (loss) $ (2,641,000) $ 2,281,000
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Income earned on investments held in Trust Account (3,714,000) (2,798,000)
Changes in operating assets and liabilities:    
(Increase) in prepaid expenses (40,000) (235,000)
Increase in accounts payable 515,000 19,000
Increase in accrued expenses and other 4,776,000 96,000
Increase in deferred compensation 270,000
Net cash used in operating activities (834,000) (637,000)
Cash flows from investing activities    
Investment of cash into Trust Account (202,256,000)
Net cash used in investing activities (202,256,000)
Cash flows from financing activities    
Proceeds from Sponsor Note 2,000
Repayment of Sponsor Note (242,000)
Proceeds from sale of Units 201,250,000
Proceeds from sale of Private Placement Units 7,801,000
Payment of underwriting discounts and reimbursements (4,075,000)
Payment of offering costs (331,000)
Net cash provided by financing activities 204,405,000
Net change in cash and cash equivalents (834,000) 1,512,000
Cash and cash equivalents – beginning of period 1,198,000 55,000
Cash and cash equivalents – end of period 364,000 1,567,000
Supplemental disclosure of noncash activities:    
Deferred underwriting costs payable 7,044,000
Deferred offering costs included in accounts payable $ 75,000